Novavax Financial Health
Financial Health criteria checks 0/6
Novavax has a total shareholder equity of $-895.6M and total debt of $166.9M, which brings its debt-to-equity ratio to -18.6%. Its total assets and total liabilities are $1.5B and $2.4B respectively.
Key information
-18.6%
Debt to equity ratio
US$166.86m
Debt
| Interest coverage ratio | n/a |
| Cash | US$624.95m |
| Equity | -US$895.58m |
| Total liabilities | US$2.44b |
| Total assets | US$1.54b |
Recent financial health updates
Recent updates
Time To Worry? Analysts Just Downgraded Their Novavax, Inc. (NASDAQ:NVAX) Outlook
Mar 05
COVID-19 remains global health emergency - WHO
Oct 19Novavax spikes ahead of presentations on COVID-19 vaccine portfolio
Oct 10US Supreme Court declines to hear challenge of COVID vaccine mandate for health workers
Oct 03Novavax makes 1M doses of its COVID-19 vaccine available for use in the UK
Sep 27EU clears Novavax's COVID-19 shot for use as a booster dose in adults
Sep 12Novavax wins EU backing for COVID-19 booster shot
Sep 01Novavax: Finding Its Niche
Aug 23Novavax COVID vaccine gets provisional approval in New Zealand as booster shot
Aug 17Novavax Q2: Time To Turn Bullish After The Massive Collapse
Aug 11Bearish: Analysts Just Cut Their Novavax, Inc. (NASDAQ:NVAX) Revenue and EPS estimates
Aug 11Novavax COVID-19 shot is linked to rare cases of heart inflammation – EU agency
Aug 03Novavax gets Japanese regulatory nod for use of its COVID vaccine in teens
Jul 26Serum Institute of India supplies Novavax's COVID vaccine in US
Jul 18Novavax to deliver 3.2M doses of COVID-19 vaccine to U.S.
Jul 11Novavax wins EU nod to use COVID-19 vaccine in adolescents
Jul 05Taiwan to get 504K doses of Novavax COVID vaccine in 1st lot this week
Jun 29Novavax seeks label expansion for COVID-19 shot in Canada
Jun 23The Novavax Vaccine, Finally
Jun 08Is Novavax (NASDAQ:NVAX) Using Debt In A Risky Way?
May 24Novavax: Buying Here Will Not End Well
May 18Novavax: Don't Catch The Falling Knives
May 07Novavax: Management's Revenue Guidance - If It Can Be Trusted - Makes The Bull Case
Apr 21Financial Position Analysis
Short Term Liabilities: NVAX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NVAX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NVAX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NVAX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVAX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NVAX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.1% each year